Examining tissue-level changes in doxorubicin accumulation and nitric oxide formation in skeletal muscle and tumours in a mouse model of breast cancer
Canadian Journal of Physiology and Pharmacology · 2025
DOI: 10.1139/cjpp-2024-0368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Meghan V McCue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomolecular Sciences, Laurentian University, Sudbury, ON, Canada. Hauptthemen laut MEDLINE: Doxorubicin, Muscle, Skeletal, Nitric Oxide, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Cancer Foundation, Canadian Cancer Society.
Abstract (Originalsprache)
Doxorubicin is a commonly used chemotherapy that rapidly accumulates in skeletal muscle and disrupts nitric oxide (NO) formation. However, studies investigating these effects have largely been performed in tumour-free models, therefore it remains unknown whether intramuscular accumulation and disruptions to NO content persist during tumour growth. Female C57bl/6 mice ( n = 8/group) were randomly assigned to true control, doxorubicin control, tumour only, or tumour plus doxorubicin groups. Tumours were grown for 21, 24, or 28 days using E0771 cells. Doxorubicin was administered as a single 10 mg/kg intraperitoneal dose on day 21. Doxorubicin accumulation was similar in muscle with and without tumours present. Doxorubicinol, a metabolite of doxorubicin, was elevated ( p < 0.05) in 24-day tumour + doxorubicin compared to doxorubicin alone. NO was similar across all groups in muscle; however, tumour NO was 15-fold higher at day 21 compared to 24, or 28 days ( p < 0.05). The results confirm that doxorubicin is sequestered in skeletal muscle when a tumour is present, which may impact bioavailability. Tumour growth transiently increased intramuscular doxorubicinol, potentially exacerbating the toxicity of the drug. Earlier stage tumour growth appeared to profoundly elevate NO, which could suggest temporal angiogenesis and vasodilation to facilitate growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomolecular Sciences, Laurentian University, Sudbury, ON, Canada.
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
- Division of Medical Sciences, NOSM University, Sudbury, ON, Canada.
ORCID-Profile: Meghan V McCue, Irena A Rebalka
Förderung
- Northern Cancer Foundation
- Canadian Cancer Society
Zitieren
APA
McCue, M., Rebalka, I., Hawke, T., & MacLean, D. (2025). Examining tissue-level changes in doxorubicin accumulation and nitric oxide formation in skeletal muscle and tumours in a mouse model of breast cancer. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2024-0368
Vancouver
McCue M, Rebalka I, Hawke T, MacLean D. Examining tissue-level changes in doxorubicin accumulation and nitric oxide formation in skeletal muscle and tumours in a mouse model of breast cancer. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2024-0368
BibTeX
@article{McCue2025,
author = {McCue, Meghan V and Rebalka, Irena A and Hawke, Thomas J and MacLean, David A},
title = {Examining tissue-level changes in doxorubicin accumulation and nitric oxide formation in skeletal muscle and tumours in a mouse model of breast cancer},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2025},
doi = {10.1139/cjpp-2024-0368}
}
EUVIMED